Inactive Instrument

QUANTA Share Price

QNTA

US74766N1081

Quanta, Inc. is an applied science company focused on increasing energy levels in plant matter to increase performance within the human body. The Company is also specialized in potentiating rare naturally occurring elements to create and sustainable solutions. The Company's technology uses quantum mechanics to increase bioactivity of targeted molecules to enhance the desired effects. The Company supports product formulations in pain management, anti-inflammation, skincare, agriculture, nutritional supplements, and plant-based consumables.

Sector

More about the company

Quanta, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	23/22/23	CI
Quanta, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	16/22/16	CI
Quanta, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	23/21/23	CI
Quanta, Inc. announced that it has received $0.075 million in funding from Trillium Partners LP	12/21/12	CI
Quanta, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	24/21/24	CI
Quanta, Inc. Appoints Grant Mikaelian and Pauline Ranjbar to the Board of Directors	02/21/02	CI
Quanta, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	25/21/25	CI
Quanta, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	16/21/16	CI
Quanta, Inc. Auditor Raises 'Going Concern' Doubt	15/21/15	CI
Quanta, Inc. completed the acquisition of 51% stake in Medolife International, Inc.	14/21/14	CI
Quanta, Inc. Announces Appointment of Arthur G. Mikaelian as Chief Executive Officer	22/20/22	CI
Quanta, Inc. Announces Appointment of Arthur G. Mikaelian as Member of the Board of Directors	22/20/22	CI
Quanta, Inc. entered into a Securities Exchange Agreement to acquire 51% stake in Medolife International, Inc.	22/20/22	CI
Quanta, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	19/20/19	CI
Quanta, Inc. Announces Change of CEO	19/20/19	CI

Quanta and Medolife Rx Provide Updates on Activities and Plans	05/22/05	AQ
QUANTA INC : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	17/22/17	AQ
QUANTA INC : Other Events (form 8-K)	27/22/27	AQ
QUANTA INC : Entry into a Material Definitive Agreement (form 8-K)	17/22/17	AQ
Medolife Rx in Discussions with a Major Infomercial Agency and Receives Exceptionally Positive Product Reviews	01/22/01	AQ

Managers	Title	Age	Since
Arthur Mikaelian CEO	Chief Executive Officer	62	21/20/21
Khalid Matalka CTO	Chief Tech/Sci/R&D Officer	59	01/21/01
Grant Mikaelian TRE	Treasurer	31	01/21/01

QUANTA Share Price

Equities

QNTA

US74766N1081

Chart QUANTA

Latest news about QUANTA

Press releases QUANTA

Managers and Directors - QUANTA

Company Profile